← Evidence map

ReviewBiomarker research2022

Sintilimab for the treatment of non-small cell lung cancer.

Lin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

26 papers cite it

2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 35436956